Medical publisher Healio, announces the launch of the new publication, Healio Psoriatic Disease
| THOROFARE, N.J., April 7, 2020 /PRNewswire/ -- Medical publisher Healio, announces the launch of the new publication, Healio Psoriatic Disease. The first issue is scheduled to be published this May.
Intended for Dermatologists, Healio Psoriatic Disease is the first publication focused on informing health care professionals about the burden of psoriatic disease and the emerging understanding of psoriasis as a systemic disease. “Healio has been tracking and reporting on the therapeutic evolution of psoriatic disease for years,” said Joan-Marie Stiglich, ELS, Healio’s Chief Content Officer. “We are excited to introduce this first-of-its-kind publication, designed to keep dermatologists up to date on developments in the rapidly evolving field of psoriatic disease.” Healio Psoriatic Disease will feature coverage of the latest peer-reviewed research, meeting news highlights and FDA approvals. Moreover, guideline overviews, therapeutic dosing schedules and expert perspectives will provide valuable insight and guidance on the psoriatic disease landscape. For advertising opportunities with Healio Psoriatic Disease and Healio.com, contact Christine Martynick, Vice President, Advertising Solutions & Agency Partnerships at 856-693-1387 or cmartynick@healio.com; or Tara Kosmowsky, National Account Manager at 610-639-4021 or tkosmowsky@healio.com. About Healio CONTACT
SOURCE Healio |
View original content to download multimedia:
